| Quellen/Referenzen |
1. Kerr1, C Graue1, K Broadbent1, JM Balada-Llasat2, A Carroll2, H Stone2, O Akerele2, B Buchan3, D Mahmutoglu3, A Hopp3, S Ronen3, RF Relich4, R Buckner4, DA Warren4, O Garner5, H Huse5, S Chandrasekaran5, A Leber6, K Everhart6, A Harrington7, C Kwong7, S Collier7,A Bonwit7, J Dien Bard8, S Naccache8, C Murphy9, R Fowler9, C Zimmerman10, B Jones10and M Rogatcheva1 1 BioFire Diagnostics LLC, Salt Lake City, UT, USA; 2 The Ohio State University WexnerMedical Center, Columbus, OH, USA; 3Medical College of Wisconsin, Milwaukee, WI, USA; 4 Indiana University School of Medicine, Indianapolis, IN, USA; 5 UCLA Health, Los Angeles, CA, USA ; 6 Nationwide Children\X92\s Hospital, Columbus, OH, USA 7 Loyola University Medical Center, Loyola, IL, USA; 8 Children\X92\s Hospital of Los Angeles, Los Angeles, CA, USA; 9 University of Nebraska Medical Center, Omaha, Nebraska, USA; 10MRIGlobal, Palm Bay, FL, USA; Clinical Evaluation of the BioFire®FilmArray®Pneumonia Panel plus 2. FilmArray Benutzer Handbuch Pneumoniae Panel Plus |